Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Bipolar Disorder01:30

Bipolar Disorder

144
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
144
Borderline Personality Disorder01:25

Borderline Personality Disorder

142
Borderline Personality Disorder is a complex and multifaceted mental health condition characterized by pervasive instability in interpersonal relationships, self-image, emotions, and impulse control. This instability manifests in extreme emotional reactions, fear of abandonment, and self-destructive behaviors. The disorder significantly impacts daily functioning, often leading to distress in both personal and professional domains.
Genetic and Environmental Contributions
Borderline Personality...
142
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

321
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
321
Personality Disorders: Schizotypal and Histrionic01:20

Personality Disorders: Schizotypal and Histrionic

165
Schizotypal personality disorder and histrionic personality disorder are two distinct psychological conditions classified under personality disorders, each characterized by unique behavioral patterns and social difficulties. Both disorders significantly affect interpersonal relationships and emotional well-being, leading to social isolation and frustration.
Schizotypal Personality Disorder: Eccentric Behavior and Social Withdrawal
Schizotypal personality disorder is marked by odd or eccentric...
165
Depression: Overview01:18

Depression: Overview

343
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
343
Panic Disorder01:27

Panic Disorder

176
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
176

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Biofluid Biomarkers of Cognitive Functioning in Bipolar Disorder: A Systematic Review by the Targeting Cognition and Older-Age Bipolar Disorder ISBD Task Forces.

Bipolar disorders·2026
Same author

Lived Experience of Suicide in Suicide Researchers.

Crisis·2026
Same author

Pharmacological maintenance treatment in older age bipolar disorder.

Current opinion in psychiatry·2026
Same author

A Chatbot for the Management of Bipolar Disorder: Using Retrieval-Augmented Generation With an Open-Weight Large Language Model to Answer Clinical Questions Based on the CANMAT and ISBD 2018 Guidelines for Bipolar Disorder: Un dialogueur pour la prise en charge du trouble bipolaire : utiliser la génération augmentée par récupération avec un grand modèle de langage (GML) à poids ouverts pour répondre aux questions cliniques fondées sur les lignes directrices de 2018 de CANMAT et de l'ISBD relatives au trouble bipolaire.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Same author

The Distinct Role of Family History and Polygenic Risk Scores of Psychiatric Disorders on Lithium Response in Bipolar Disorder.

Bipolar disorders·2026
Same author

Task Forces of the International Society for Bipolar Disorders: Reflections on the Past, Present, and Future.

Bipolar disorders·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: Sep 13, 2025

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

453

双極性障害

Balwinder Singh1, Holly A Swartz2, Alfredo B Cuellar-Barboza3

  • 1Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.

Lancet (London, England)
|July 25, 2025
PubMed
まとめ
この要約は機械生成です。

双極性障害は 世界中で4千万人に影響を与え 診断の難しさと 重大な負担を伴います ケタミンのような新しい治療法を探求し 患者のケアを改善しています

さらに関連する動画

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.5K
Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
08:33

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

9.9K

関連する実験動画

Last Updated: Sep 13, 2025

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

453
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.5K
Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
08:33

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

9.9K

科学分野:

  • 精神医学 と 神経科学
  • メンタルヘルスの研究

背景:

  • 双極性障害はマニア/ヒポマニアとうつ病によって特徴付けられ,世界中で4千万人に影響を与えます.
  • 心理的・社会的・医療的・経済的負担があり 死亡リスクも高まります
  • 症状が他の精神疾患と重なり合っているため,診断の遅延は一般的です.

研究 の 目的:

  • 双極性障害の病理生理学と危険因子の現在の理解をレビューする.
  • 現在の治療戦略と新たな治療戦略を概説する.
  • 双極性障害の研究と治療の 将来の方向性を特定する

主な方法:

  • 双極性障害の研究における最近の進歩の文献レビュー.
  • 遺伝的,感染症的,ミトコンドリア的原因に関する情報の合成
  • 薬剤療法,心理療法,ライフスタイルの改変のアプローチの概要
  • 新しい介入と将来の研究方法の探求

主要な成果:

  • 多遺伝子リスク,感染症,ミトコンドリア要因は双極性障害に 関わっている.
  • 患者中心の薬物療法,心理療法,ライフスタイルの変化は 治療の重要な要素です.
  • ケタミン,エスケタミン,神経調節などの新しい治療法は有望です.

結論:

  • 標的治療の開発には 病理生理学の研究が不可欠です
  • 心理社会的な介入へのアクセスを拡大し,治療抵抗性に対処することが優先事項です.
  • 将来のケアでは,新しい薬理学と神経調節技術が統合され,総合的な治療が可能になります.